Advertisement
Screener

Proto Labs Inc (PRLB) Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities

2.8 / 5 stars · 68/120 Roast Me

Proto Labs Inc Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities

Proto Labs Inc (PRLB) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $5.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-07-31

  • Proto Labs Inc increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $556.00K, a 62.33% decline year-over-year.
  • Proto Labs Inc increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$551.00K, a 108.47% decline year-over-year.
  • Proto Labs Inc increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was -$1.93M.
  • Proto Labs Inc increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $7.93M, a 204.65% increase year-over-year.
  • Proto Labs Inc increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $13.97M, a 1573.65% increase from fiscal 2024.
  • Proto Labs Inc increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $835.00K.
  • Proto Labs Inc increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was -$1.45M, a 414.75% decline from fiscal 2022.
  • Proto Labs Inc increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $461.00K.
Period endIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month
2026-06-30$556.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31
$5.00K
10-Q · filed 2026-07-31
-$1.93M
derived: sum of 3 quarters · filed 2026-07-31
$6.00M
derived: sum of 4 quarters · filed 2026-07-31
2026-03-31-$551.00K
10-Q · filed 2026-05-01
-$2.48M
derived: sum of 2 quarters · filed 2026-05-01
$5.44M
derived: sum of 3 quarters · filed 2026-05-01
$6.92M
derived: sum of 4 quarters · filed 2026-07-31
2025-12-31-$1.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20
$6.00M
derived: sum of 2 quarters · filed 2026-02-20
$7.47M
derived: sum of 3 quarters · filed 2026-07-31
$13.97M
10-K · filed 2026-02-20
2025-09-30$7.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31
$9.40M
derived: sum of 2 quarters · filed 2026-07-31
$15.91M
10-Q · filed 2025-10-31
$12.59M
derived: sum of 4 quarters · filed 2026-07-31
2025-06-30$1.48M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31
$7.98M
10-Q · filed 2026-07-31
$4.66M
derived: sum of 3 quarters · filed 2026-07-31
$7.26M
derived: sum of 4 quarters · filed 2026-07-31
2025-03-31$6.50M
10-Q · filed 2026-05-01
$3.19M
derived: sum of 2 quarters · filed 2026-05-01
$5.79M
derived: sum of 3 quarters · filed 2026-05-01
$2.56M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31-$3.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20
-$716.00K
derived: sum of 2 quarters · filed 2026-02-20
-$3.94M
derived: sum of 3 quarters · filed 2026-02-20
$835.00K
10-K · filed 2026-02-20
2024-09-30$2.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31
-$626.00K
derived: sum of 2 quarters · filed 2025-10-31
$4.15M
10-Q · filed 2025-10-31
-$1.54M
derived: sum of 4 quarters · filed 2026-02-20
2024-06-30-$3.23M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31
$1.55M
10-Q · filed 2025-07-31
-$4.14M
derived: sum of 3 quarters · filed 2026-02-20
$2.73M
derived: sum of 4 quarters · filed 2026-02-20
2024-03-31$4.78M
10-Q · filed 2025-05-02
-$914.00K
derived: sum of 2 quarters · filed 2026-02-20
$5.96M
derived: sum of 3 quarters · filed 2026-02-20
-$172.00K
derived: sum of 4 quarters · filed 2026-02-20
2023-12-31-$5.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20
$1.18M
derived: sum of 2 quarters · filed 2026-02-20
-$4.95M
derived: sum of 3 quarters · filed 2026-02-20
-$1.45M
10-K · filed 2026-02-20
2023-09-30$6.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$742.00K
derived: sum of 2 quarters · filed 2024-11-07
$4.24M
10-Q · filed 2024-11-07
-$3.66M
derived: sum of 4 quarters · filed 2025-02-21
2023-06-30-$6.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02
-$2.63M
10-Q · filed 2024-08-02
-$10.53M
derived: sum of 3 quarters · filed 2025-02-21
-$10.28M
derived: sum of 4 quarters · filed 2025-02-21
2023-03-31$3.50M
10-Q · filed 2024-05-03
-$4.41M
derived: sum of 2 quarters · filed 2025-02-21
-$4.15M
derived: sum of 3 quarters · filed 2025-02-21
$1.07M
derived: sum of 4 quarters · filed 2025-02-21
2022-12-31-$7.91M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21
-$7.65M
derived: sum of 2 quarters · filed 2025-02-21
-$2.43M
derived: sum of 3 quarters · filed 2025-02-21
$461.00K
10-K · filed 2025-02-21
2022-09-30$251.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
$5.47M
derived: sum of 2 quarters · filed 2023-11-03
$8.37M
10-Q · filed 2023-11-03
$5.18M
derived: sum of 4 quarters · filed 2024-02-16
2022-06-30$5.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
$8.12M
10-Q · filed 2023-08-04
$4.92M
derived: sum of 3 quarters · filed 2024-02-16
$1.78M
derived: sum of 4 quarters · filed 2024-02-16
2022-03-31$2.89M
10-Q · filed 2023-05-05
-$296.00K
derived: sum of 2 quarters · filed 2024-02-16
-$3.44M
derived: sum of 3 quarters · filed 2024-02-16
-$1.63M
derived: sum of 4 quarters · filed 2024-02-16
2021-12-31-$3.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16
-$6.33M
derived: sum of 2 quarters · filed 2024-02-16
-$4.52M
derived: sum of 3 quarters · filed 2024-02-16
-$7.08M
10-K · filed 2024-02-16
2021-09-30-$3.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04
-$1.33M
derived: sum of 2 quarters · filed 2022-11-04
-$3.89M
10-Q · filed 2022-11-04
-$8.20M
derived: sum of 4 quarters · filed 2023-02-21
2021-06-30$1.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05
-$748.00K
10-Q · filed 2022-08-05
-$5.05M
derived: sum of 3 quarters · filed 2023-02-21
2021-03-31-$2.56M
10-Q · filed 2022-05-06
-$6.87M
derived: sum of 2 quarters · filed 2023-02-21
2020-12-31-$4.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21
$4.08M
10-K · filed 2023-02-21
2020-09-30$8.38M
10-Q · filed 2021-11-02
2019-12-31-$4.04M
10-K · filed 2022-02-18

Similar stocks

Stock NameCountryMarket CapPE Ratio
INNOVATE Corp. (VATE)United States$0.102B
TECHPRECISION CORP (TPCS)United States$0.053B108.37
Arcosa, Inc. (ACA)United States$7.195B14.51
VALMONT INDUSTRIES INC (VMI)United States$8.988B22.19